EUCAST expert rules in antimicrobial susceptibility testing
Open accessThe DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Updated Functional Classification of β-Lactamases
Bush, K., & Jacoby, G. A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01009-09 · Cited by 2,367 · cited 3×
“b e n zy lp e n ic ill in , am p ic ill in , an d am o x yc ill in C [9 9 ]”
Backgroundbeta-Lactamases in laboratory and clinical resistance
Livermore, D. M. (1995) · Clinical Microbiology Reviews · doi:10.1128/cmr.8.4.557 · Cited by 1,779
Jarlier, V., Nicolas, M.-H., Fournier, G., & Philippon, A. (1988) · Clinical Infectious Diseases · doi:10.1093/clinids/10.4.867 · Cited by 1,559
Metallo-β-Lactamases: the Quiet before the Storm?
Walsh, T. R., Toleman, M. A., Poirel, L., & Nordmann, P. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.2.306-325.2005 · Cited by 1,431
Self-citationShaw, K. J., Rather, P. N., Hare, R. S., & Miller, G. H. (1993) · Microbiological Reviews · doi:10.1128/mmbr.57.1.138-163.1993 · Cited by 1,196
Leclercq, R. (2002) · Clinical Infectious Diseases · doi:10.1086/324626 · Cited by 1,102
Self-citationQuinolone resistance from a transferable plasmid
Martínez-Martínez, L., Pascual, A., & Jacoby, G. A. (1998) · The Lancet · doi:10.1016/s0140-6736(97)07322-4 · Cited by 1,100
Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase
Robicsek, A., Strahilevitz, J., Jacoby, G. A., Macielag, M., Abbanat, D., Hye Park, C., Bush, K., & Hooper, D. C. (2006) · Nature Medicine · doi:10.1038/nm1347 · Cited by 1,013
Emergence of Oxacillinase-Mediated Resistance to Imipenem in Klebsiella pneumoniae
Poirel, L., Héritier, C., Tolün, V., & Nordmann, P. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.1.15-22.2004 · Cited by 997
Self-citationThe worldwide emergence of plasmid-mediated quinolone resistance
Robicsek, A., Jacoby, G. A., & Hooper, D. C. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70599-0 · Cited by 966
The porin and the permeating antibiotic: a selective diffusion barrier in Gram-negative bacteria
Pagès, J.-M., James, C. E., & Winterhalter, M. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1994 · Cited by 939
Mechanisms of Resistance to Quinolones
Jacoby, G. A. (2005) · Clinical Infectious Diseases · doi:10.1086/428052 · Cited by 924
Enterobacter Bacteremia: Clinical Features and Emergence of Antibiotic Resistance during Therapy
Chow, J. W., Fine, M. J., Shlaes, D. M., Quinn, J. P., Hooper, D. C., Johnson, M. P., Ramphal, R., Wagener, M. M., Miyashiro, D. K., & Yu, V. L. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-8-585 · Cited by 889
Mechanisms of Multidrug Resistance in Acinetobacter Species and Pseudomonas aeruginosa
Bonomo, R. A., & Szabo, D. (2006) · Clinical Infectious Diseases · doi:10.1086/504477 · Cited by 741
Penicillin-binding proteins and β-lactam resistance
Zapun, A., Contreras-Martel, C., & Vernet, T. (2008) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2007.00095.x · Cited by 687
Versatility of Aminoglycosides and Prospects for Their Future
Vakulenko, S. B., & Mobashery, S. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.3.430-450.2003 · Cited by 643
Has the era of untreatable infections arrived?
Livermore, D. M. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp255 · Cited by 620
16S Ribosomal RNA Methylation: Emerging Resistance Mechanism against Aminoglycosides
Doi, Y., & Arakawa, Y. (2007) · Clinical Infectious Diseases · doi:10.1086/518605 · Cited by 571
Efflux pumps as antimicrobial resistance mechanisms
Poole, K. (2007) · Annals of Medicine · doi:10.1080/07853890701195262 · Cited by 562
Paterson, D. L., Ko, W.-C., Von Gottberg, A., Casellas, J. M., Mulazimoglu, L., Klugman, K. P., Bonomo, R. A., Rice, L. B., McCormack, J. G., & Yu, V. L. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.6.2206-2212.2001 · Cited by 546
Resistance to Levofloxacin and Failure of Treatment of Pneumococcal Pneumonia
Davidson, R., Cavalcanti, R., Brunton, J. L., Bast, D. J., de Azavedo, J. C. S., Kibsey, P., Fleming, C., & Low, D. E. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012122 · Cited by 533
Antimicrobial Resistance in Haemophilus influenzae
Tristram, S., Jacobs, M. R., & Appelbaum, P. C. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00040-06 · Cited by 464
Bacterial resistance to aminoglycoside antibiotics
Davies, J., & Wright, G. D. (1997) · Trends in Microbiology · doi:10.1016/s0966-842x(97)01033-0 · Cited by 403
Excess Mortality Associated with Antimicrobial Drug-Resistant Salmonella Typhimurium
Helms, M., Vastrup, P., Gerner-Smidt, P., & Mølbak, K. (2002) · Emerging Infectious Diseases · doi:10.3201/eid0805.010267 · Cited by 369
Komp Lindgren, P., Karlsson, A., & Hughes, D. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.10.3222-3232.2003 · Cited by 350
Molecular understanding of aminoglycoside action and resistance
Jana, S., & Deb, J. K. (2006) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-005-0279-0 · Cited by 336
Aminoglycoside Resistance in Enterococci
Chow, J. W. (2000) · Clinical Infectious Diseases · doi:10.1086/313949 · Cited by 332
Lewis, J. S., & Jorgensen, J. H. (2005) · Clinical Infectious Diseases · doi:10.1086/426894 · Cited by 313
Carbapenemases: Molecular Diversity and Clinical Consequences
Poirel, L., Pitout, J. D., & Nordmann, P. (2007) · Future Microbiology · doi:10.2217/17460913.2.5.501 · Cited by 309
Self-citationDetection of β-lactamase-mediated resistance
Livermore, D. M., & Brown, D. F. J. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/48.suppl_1.59 · Cited by 307
Self-citationPlasmid-mediated quinolone resistance: an update
Rodríguez-Martínez, J. M., Velasco, C., Pascual, Á., Cano, M. E., Martínez-Martínez, L., Martínez-Martínez, L., & Pascual, Á. (2011) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-010-0120-2 · Cited by 306
First Molecular Characterization of Group B Streptococci with Reduced Penicillin Susceptibility
Kimura, K., Suzuki, S., Wachino, J.-I., Kurokawa, H., Yamane, K., Shibata, N., Nagano, N., Kato, H., Shibayama, K., & Arakawa, Y. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00185-08 · Cited by 306
Rodriguez-Bano, J., Navarro, M. D., Romero, L., Muniain, M. A., Cueto, M. D., Rios, M. J., Hernandez, J. R., & Pascual, A. (2006) · Clinical Infectious Diseases · doi:10.1086/508877 · Cited by 279
Aminoglycoside-modifying enzymes
Wright, G. D. (1999) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(99)00007-7 · Cited by 241
Daikos, G. L., & Markogiannakis, A. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03553.x · Cited by 238
High-Level Resistance to Gentamicin in Clinical Isolates of Enterococci
Mederski-Samoraj, B. D., & Murray, B. E. (1983) · Journal of Infectious Diseases · doi:10.1093/infdis/147.4.751 · Cited by 213
Daikos, G. L., Petrikkos, P., Psichogiou, M., Kosmidis, C., Vryonis, E., Skoutelis, A., Georgousi, K., Tzouvelekis, L. S., Tassios, P. T., Bamia, C., et al. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00782-08 · Cited by 210
Ropp, P. A., Hu, M. Y., Olesky, M., & Nicholas, R. A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.3.769-777.2002 · Cited by 206
Nagai, K., Davies, T. A., Jacobs, M. R., & Appelbaum, P. C. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.5.1273-1280.2002 · Cited by 167
Aminoglycoside-modifying enzymes: mechanisms of catalytic processes and inhibition
Azucena, E., & Mobashery, S. (2001) · Drug Resistance Updates · doi:10.1054/drup.2001.0197 · Cited by 166
Olesky, M., Zhao, S., Rosenberg, R. L., & Nicholas, R. A. (2006) · Journal of Bacteriology · doi:10.1128/jb.188.7.2300-2308.2006 · Cited by 153
R‐factor mediated gentamicin resistance: A new enzyme which modifies aminoglycoside antibiotics
Benveniste, R. Ė., & DAVIES, J. E. (1971) · FEBS Letters · doi:10.1016/0014-5793(71)80282-x · Cited by 139
Detection of methicillin/oxacillin resistance in staphylococci
Brown, D. F. J. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/48.suppl_1.65 · Cited by 138
Self-citationExpert Systems in Clinical Microbiology
Winstanley, T. G., & Courvalin, P. M. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00061-10 · Cited by 137
Self-citationPenicillins: A Current Review of their Clinical Pharmacology and Therapeutic Use
Nathwani, D., & Wood, M. (1993) · Drugs · doi:10.2165/00003495-199345060-00002 · Cited by 131
Wong‐Beringer, A., Hindler, J. A., Loeloff, M. J., Queenan, A. M., Lee, N., Pegues, D. A., Quinn, J. P., & Bush, K. (2002) · Clinical Infectious Diseases · doi:10.1086/324742 · Cited by 125
The mode of action of 4-quinolones and possible mechanisms of resistance
Smith, J. T. (1986) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/18.supplement_d.21 · Cited by 125
Enterococci Acquire New Kinds of Resistance
Leclercq, R. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.supplement_1.s80 · Cited by 124
Self-citationClinical implications of antimicrobial resistance for therapy
MacGowan, A. P., & Surveillance, O. B. O. T. B. W. P. O. R. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn357 · Cited by 122
Self-citationPlasmid-mediated quinolone resistance
Martínez-Martínez, L., Cano, M. E., Rodríguez-Martínez, J. M., Calvo, J., & Pascual, Á. (2008) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.6.5.685 · Cited by 117
Kadhiravan, T., Wig, N., Kapil, A., Kabra, S., Renuka, K., & Misra, A. (2005) · BMC Infectious Diseases · doi:10.1186/1471-2334-5-37 · Cited by 114
Mechanisms of Resistance to Imipenem and Ampicillin in Enterococcus faecalis
Ono, S., Muratani, T., & Matsumoto, T. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.7.2954-2958.2005 · Cited by 111
Fluoroquinolone‐ResistantStreptococcus pneumoniaeAssociated with Levofloxacin Therapy
Urban, C. M., Rahman, N. A., Zhao, X., Mariano, N., Segal‐Maurer, S., Drlica, K., & Rahal, J. J. (2001) · The Journal of Infectious Diseases · doi:10.1086/323086 · Cited by 110
Breakpoints for intravenously used cephalosporins in Enterobacteriaceae—EUCAST and CLSI breakpoints
Kahlmeter, G. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01856.x · Cited by 94
Self-citationMartin, P., Jullien, E., & Courvalin, P. M. (1988) · Molecular Microbiology · doi:10.1111/j.1365-2958.1988.tb00070.x · Cited by 85
Dillon, J.-A. R., & Yeung, K. H. (1989) · Clinical Microbiology Reviews · doi:10.1128/cmr.2.suppl.s125 · Cited by 77
Gavin, P. J., Suseno, M. T., Thomson, R. B., Gaydos, J. M., Pierson, C. L., Halstead, D. C., Aslanzadeh, J., Brecher, S., Rotstein, C., Brossette, S. E., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00381-05 · Cited by 76
Casey, J. R., & Pichichero, M. E. (2004) · Clinical Infectious Diseases · doi:10.1086/392496 · Cited by 75
Intrinsic Penicillin Resistance in Enterococci
Fontana, R., Ligozzi, M., Pittaluga, F., & Satta, G. (1996) · Microbial Drug Resistance · doi:10.1089/mdr.1996.2.209 · Cited by 72
Correlation between aminoglycoside resistance profiles and DNA hybridization of clinical isolates
Shaw, K. J., Hare, R. S., Sabatelli, F., Rizzo, M. F., Cramer, C. A., Naples, L., Kocsi, S., MUNAYYER, H., Mann, P. A., & Miller, G. H. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.11.2253 · Cited by 72
Slinger, R., Desjardins, M., McCarthy, A. E., Ramotar, K., Jessamine, P. G., Guibord, C., & Toye, B. (2004) · BMC Infectious Diseases · doi:10.1186/1471-2334-4-36 · Cited by 69
Bhavnani, S. M., Ambrose, P. G., Craig, W. A., Dudley, M. N., & Jones, R. N. (2006) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2005.09.011 · Cited by 69
Tato, M., Morosini, M., García, L., Albertí, S., Coque, M. T., & Cantón, R. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.01130-10 · Cited by 66
Jones, M. E., Draghi, D. C., Karlowsky, J. A., Sahm, D. F., & Bradley, J. S. (2004) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/1476-0711-3-3 · Cited by 57
Fantin, B., Leclercq, R., Garry, L., & Carbon, C. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.5.931 · Cited by 51
Self-citationSchwaber, M. J., Graham, C. S., Sands, B. E., Gold, H. S., & Carmeli, Y. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.6.1882-1886.2003 · Cited by 48
TRANSFERABLE RESISTANCE AND AMINOGLYCOSIDE-MODIFYING ENZYMES IN ENTEROCOCCI
Chen, H. Y., & Williams, J. D. (1985) · Journal of Medical Microbiology · doi:10.1099/00222615-20-2-187 · Cited by 41
Potz, N. A. C. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh112 · Cited by 41
Galimand, M., Lambert, T., Gerbaud, G., & Courvalin, P. M. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.7.1456 · Cited by 39
Montanari, M. P., Tili, E., Cochetti, I., Mingoia, M., Manzin, A., & Varaldo, P. E. (2004) · Microbial Drug Resistance · doi:10.1089/mdr.2004.10.209 · Cited by 21
Cited by
The global threat of antimicrobial resistance: science for intervention.
Roca, I., Akova, M., Baquero, F., Carlet, J., Cavaleri, M., Coenen, S., Cohen, J., Findlay, D., Gyssens, I., Heure, O. E., et al. (2015) · New Microbes and New Infections · doi:10.1016/j.nmni.2015.02.007 · Cited by 1,106
“Published by Elsevier Ltd on beha This is an open access arti treatable with the agent) to guide therapy [26].”
BackgroundSelf-citationOXA-48-like carbapenemases: the phantom menace
Poirel, L., Potron, A., & Nordmann, P. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks121 · Cited by 924
Self-citationEllington, M. J., Ekelund, O., Aarestrup, F. M., Canton, R., Doumith, M., Giske, C., Grundman, H., Hasman, H., Holden, M. T. G., Hopkins, K. L., et al. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.11.012 · Cited by 603
Self-citationMechanisms of antimicrobial resistance in Gram-negative bacilli
Ruppé, É., Woerther, P.-L., & Barbier, F. (2015) · Annals of Intensive Care · doi:10.1186/s13613-015-0061-0 · Cited by 490
Identification and screening of carbapenemase-producing Enterobacteriaceae
Nordmann, P., Gniadkowski, M., Giske, C. G., Poirel, L., Woodford, N., & Miriagou, V. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03815.x · Cited by 408
Self-citation
Metadata
- Authors
- Leclercq, R., Cantón, R., Brown, D. F. J., Giske, C. G., Heisig, P., MacGowan, A. P., Mouton, J. W., Nordmann, P., Rodloff, A. C., Rossolini, G. M., Soussy, C.-J., Steinbakk, M., Winstanley, T. G., & Kahlmeter, G.
- Venue
- Clinical Microbiology and Infection
- Publisher
- Elsevier BV
- Published
- 2013-02
- Volume
- 19
- Issue
- 2
- Pages
- 141-160
- ISSN
- 1198-743X (ISSN-L)
- OpenAlex
- W2102217986
- Cited by
- 683
- References
- 70
- FWCI
- 15.66
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.